Kymera Therapeutics, Inc.

Fintech firm providing data analytics and market intelligence for investment professionals.

KYMR | NDAQ

Overview

Corporate Details

ISIN(s):: US5015751044
LEI:
Country:: United States of America
Address:: 500 NORTH BEACON STREET, 4TH FLOOR, 2472 WATERTOWN
Website:: https://www.kymeratx.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Kymera Therapeutics, Inc. is a revolutionary financial technology firm redefining investment paradigms through targeted data analytics. Leveraging its powerful and highly productive data discovery engine, the company delivers a pipeline of first-in-class analytics and market intelligence solutions for financial institutions and investment professionals. Kymera's platform provides a market-agnostic modality for discovering alpha and managing risk, fundamentally changing how clients access and utilize data. The firm is committed to delivering transformative insights with precision, focus, and a sense of urgency to a global client base.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
	2025-11-04 13:15	Quarterly Report 10-Q - Kymera Therapeutics, Inc. (0001815442) (Filer)	English	2.2 MB
	2025-11-04 13:10	Regulatory News Service 8-K - Kymera Therapeutics, Inc. (0001815442) (Filer)	English	225.9 KB

Automate Your Workflow. Get a real-time feed of all Kymera Therapeutics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Kymera Therapeutics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Kymera Therapeutics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Mare Nostrum Comprehensive HR solutions provider for recruitment, temporary work, training, and wage portage.	France	ALMAR
Marubeni Construction Material Lease Co.,Ltd. Leases and sells temporary steel materials and offers engineering for major construction projects.	Japan	9763
MATCHING SERVICE JAPAN CO.,LTD. Specialized recruitment firm connecting legal, finance, and accounting experts with top companies.	Japan	6539
Material Group inc. A professional services firm offering PR consulting, marketing, and brand strategy.	Japan	156A
Medesis Pharma S.A. Develops therapies for CNS disorders and radiation exposure via a drug delivery platform.	France	ALMDP
MEDICINOVA INC Developing small-molecule therapies for neurological, respiratory, and fibrotic diseases.	United States of America	MNOV
Medicofarma Biotech Spolka Akcyjna A biotech R&D company developing innovative drugs and devices with a focus on oncology therapies.	Poland	MDB
Medpace Holdings, Inc. Global CRO providing full-service clinical development to biotech, pharma & medical device industries.	United States of America	MEDP
MedPacto, Inc. Develops biomarker-based precision therapies for oncology and other incurable diseases.	South Korea	235980
Medrx Co.,Ltd. Develops and licenses transdermal drug delivery systems for the pharmaceutical industry.	Japan	4586